Literature DB >> 1450214

Influence of an increased intake of linoleic acid on the incorporation of dietary (n-3) fatty acids in phospholipids and on prostanoid synthesis in rat tissues.

D Raederstorff1, U Moser.   

Abstract

We investigated whether the amount of dietary linoleic acid (LA) (as corn oil) influences the incorporation of dietary eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) in tissue phospholipids and the prostanoid biosynthesis. Rats were fed four different levels of corn oil (at a total dietary fat level of either 2.5%, 5%, 10% or 20%); at each corn oil level, two groups of rats were supplemented with either EPA and DHA (200 mg/day) during 6 weeks, and compared with a group receiving oleic acid. The phospholipid fatty acid composition of liver, kidney and aorta showed, as expected, that the incorporation of EPA was highly suppressed by increasing the content of dietary linoleic acid in the diets. On the other hand, DHA was almost unaffected by the amounts of (n - 6) fatty acids in the diets. These results indicate that EPA levels but not DHA levels in tissue phospholipids were influenced by the competing dietary (n - 6) fatty acids. The tissue arachidonate content was similar under the various dietary linoleic acid conditions, but feeding EPA or DHA lowers the AA content. Moreover, the amount of dietary linoleic acid did not significantly influence the prostaglandin E2 (PGE2) production in stimulated aortic rings. However, PGE2 synthesis was significantly decreased in the groups treated with either EPA or DHA. Thromboxane B2 levels in serum followed a similar pattern. It is suggested that an increase of dietary (n - 3) PUFAs is more efficient to reduce (n - 6) eicosanoid formation than a decrease of dietary (n - 6) fatty acids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1450214     DOI: 10.1016/0005-2760(92)90187-z

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Dietary linoleic acid, immune inhibition and disease.

Authors:  A M Sammon
Journal:  Postgrad Med J       Date:  1999-03       Impact factor: 2.401

2.  Incorporation and metabolism of trans 20:5 in endothelial cells. Effect on prostacyclin synthesis.

Authors:  C Loï; J M Chardigny; C Cordelet; L Leclere; M Genty; C Ginies; J P Noël; J L Sébédio
Journal:  Lipids       Date:  2000-08       Impact factor: 1.880

3.  Dietary n-3 polyunsaturated fatty acids affect the development of renovascular hypertension in rats.

Authors:  D Rousseau; C Héliès-Toussaint; D Raederstorff; D Moreau; A Grynberg
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

4.  Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference.

Authors:  L Madsen; A C Rustan; H Vaagenes; K Berge; E Dyrøy; R K Berge
Journal:  Lipids       Date:  1999-09       Impact factor: 1.880

5.  Low-dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues.

Authors:  G Calviello; P Palozza; P Franceschelli; G M Bartoli
Journal:  Lipids       Date:  1997-10       Impact factor: 1.880

6.  Erythrocyte fatty acids and prostate cancer risk: a comparison of methods.

Authors:  J Shannon; J O'Malley; M Mori; M Garzotto; A J Palma; I B King
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-07-14       Impact factor: 4.006

7.  Complexity of understanding the role of dietary and erythrocyte docosahexaenoic acid (DHA) on the cognitive performance of school-age children.

Authors:  Kelly A Mulder; Roger A Dyer; Rajavel Elango; Sheila M Innis
Journal:  Curr Dev Nutr       Date:  2022-06-16

8.  The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype.

Authors:  Maaike M B W Dooper; Lianne Wassink; Laura M'Rabet; Yvo M F Graus
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.